Hind limb BMD

1 paper1 finding

Animals1

Interventions

1

PG-110

upin mice1

1 study

PG-110 increases hind limb BMD in mice.
“PG-110 treatment markedly increased hind limb BMD”
Animalsin diet-induced obese micetwo weeks
PG-110, a Novel Bispecific Antibody Targeting ActRII and Myostatin, Enhances Fat-Specific Weight Loss and Improves Bone Health in Combination with GLP-1 Agonist Therapy
ADA Scientific Sessions 2025 abstract13 Jun 2025

Latest

ADA Scientific Sessions 2025 Abstract13 Jun

PG-110, a Novel Bispecific Antibody Targeting ActRII and Myostatin, Enhances Fat-Specific Weight Loss and Improves Bone Health in Combination with GLP-1 Agonist Therapy

Experiments in miceGLP-1 receptor agonists